(PharmaNewsWire.Com, November 14, 2019 ) The major factors driving the growth of this market include the growing incidence of diseases and disorders, development of enhanced solutions and improved image analysis, and growing use of high-throughput flow cytometry and automated hematology analyzers.
Market Size The global Cell Counting Market is expected to grow from USD 8.29 billion in 2017 to USD 12.31 billion by 2023, at a CAGR of 6.8% from 2018 to 2023.
“By product, the consumables segment is expected to account for the largest share of the cell counting market in 2018” On the basis of product, the consumables segment is expected to account for the largest share of the global cell counting market in 2018. This large share can be attributed to the repeated consumption of consumables and accessories in various cell counting procedures.
“By application, the research applications segment is estimated to hold the largest share in 2018” Based on application, the cell counting market is segmented into research applications, clinical & diagnostic applications, and industrial applications. In 2018, the research applications segment is expected to account for the largest share of the cell counting market.
Recent Developments • In 2017, the Danaher Corporation launched two new flow cytometry systems. With a strong portfolio of cell analysis instruments and incessant efforts to develop innovative products, the company is likely to maintain its strong position in this market in the coming years. • The Thermo Fisher has launched its new spectrophotometer units in 2018. The company’s FDA and CE Mark-approved products have helped it to further enhance its presence in this market.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
